pamidronate has been researched along with Recrudescence in 41 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate seems to be a very effective mode of therapy for patients with the SAPHO syndrome, by promoting remission in all components of the disorder, such as bone, joint and skin involvement, and ceases the bouts that characterize this disorder." | 9.11 | SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. ( Aamar, S; Amital, H; Applbaum, YH; Daniel, N; Rubinow, A, 2004) |
| "There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)." | 7.76 | Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010) |
| "We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative." | 7.74 | Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007) |
| "The response to the bisphosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures." | 7.69 | Hypercalcaemia in osteogenesis imperfecta treated with pamidronate. ( Ball, RJ; Smith, RA; Wilkinson, H; Williams, CJ, 1997) |
| "Thalidomide is an effective maintenance therapy in patients with multiple myeloma." | 6.72 | Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. ( Attal, M; Avet-Loiseau, H; Benboubker, L; Berthou, C; Bourhis, JH; Caillot, D; Doyen, C; Dumontet, C; Facon, T; Garderet, L; Grobois, B; Harousseau, JL; Hulin, C; Leyvraz, S; Marit, G; Monconduit, M; Moreau, P; Pegourie, B; Renaud, M; Voillat, L; Yakoub Agha, I, 2006) |
| "Pamidronate seems to be a very effective mode of therapy for patients with the SAPHO syndrome, by promoting remission in all components of the disorder, such as bone, joint and skin involvement, and ceases the bouts that characterize this disorder." | 5.11 | SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. ( Aamar, S; Amital, H; Applbaum, YH; Daniel, N; Rubinow, A, 2004) |
| "Bisphosphonates are now the standard treatment for tumor-induced hypercalcemia (TIH), and pamidronate can normalize serum Ca in at least 90% of the patients treated for the first time." | 5.09 | Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia. ( Body, JJ; Dumon, JC; Louviaux, I, 2000) |
| "There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)." | 3.76 | Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010) |
| "We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative." | 3.74 | Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007) |
| "The response to the bisphosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures." | 3.69 | Hypercalcaemia in osteogenesis imperfecta treated with pamidronate. ( Ball, RJ; Smith, RA; Wilkinson, H; Williams, CJ, 1997) |
| "Thalidomide is an effective maintenance therapy in patients with multiple myeloma." | 2.72 | Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. ( Attal, M; Avet-Loiseau, H; Benboubker, L; Berthou, C; Bourhis, JH; Caillot, D; Doyen, C; Dumontet, C; Facon, T; Garderet, L; Grobois, B; Harousseau, JL; Hulin, C; Leyvraz, S; Marit, G; Monconduit, M; Moreau, P; Pegourie, B; Renaud, M; Voillat, L; Yakoub Agha, I, 2006) |
| "Pamidronate is a safe, welltolerated, and effective treatment for Paget's disease." | 2.68 | Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. ( Bhagat, CI; Gutteridge, DH; Kent, GN; Nicholson, GC; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Thompson, RI; Ward, LC, 1996) |
| "Specific treatment of cancer remains essential to prevent TIH relapse." | 2.41 | [Tumor-induced hypercalcemia. Review of bisphosphonate treatment]. ( Lortholary, A, 2001) |
| "Progressive multiple myeloma may manifest features of 'de-differentiation', including a plasmablastic appearance, failure to secrete paraprotein, extramedullary involvement, and resistance to treatment." | 2.41 | Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation. ( Balmaceda, C; Mansukhani, M; Mears, JG; Orazi, A; Rescigno, J; Savage, DG; Shendrik, I, 2002) |
| "CRMO associated with ulcerative colitis (UC) is very rarely reported." | 1.39 | Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis. ( Kim, HS; Kim, YS; Lee, J, 2013) |
| "Pamidronate was administered intravenously up to four times a year." | 1.37 | Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. ( de Jong, E; Hamdy, NA; Kuijpers, SC; van Merkesteyn, JP, 2011) |
| "Several studies have suggested that Langerhans cell histiocytosis (LCH) is responsive to treatment with bisphosphonates (BPs)." | 1.37 | Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan. ( Anan, T; Hama, A; Imamura, T; Kamizono, J; Kanegane, H; Kinoshita, A; Kudo, K; Miyaji, R; Morimoto, A; Nagatoshi, Y; Nakadate, H; Nakagawa, S; Sato, T; Shioda, Y; Tauchi, H; Yabe, M; Yasui, M, 2011) |
| "Five patients with CRMO, all of whom had ongoing pain and loss of function despite conventional treatment with non-steroidal anti-inflammatory agents, were treated with pamidronate (1 mg/kg/dose with a dosing frequency of 2 to 4 monthly for a total treatment duration of 12 to 42 months)." | 1.35 | Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. ( Allen, RC; Simm, PJ; Zacharin, MR, 2008) |
| "Mild anterior uveitis is an unfamiliar adverse effect of pamidronate therapy." | 1.34 | Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost. ( Palimar, P; Quah, S; Ramasamy, B; Sahni, JN, 2007) |
| "Over last 10 years, cases of jaw bone necrosis have been associated with the use of bisphosphonate therapy." | 1.33 | Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. ( Corradi, D; Manfredi, M; Meleti, M; Merigo, E; Vescovi, P, 2005) |
| "A patient with multiple myeloma who developed hypercalcemia during three different stages of his disease, with a different hypercalcemic agent elevated in his serum on each occasion, is described." | 1.32 | Hypercalcemia due to sun exposure in a patient with multiple myeloma and elevated parathyroid hormone-related protein. ( Bergi-Stamatelou, M; Karga, H; Papapetrou, PD; Thanou, S, 2003) |
| "To find an effective symptomatic treatment for osteogenesis imperfecta (OI)." | 1.31 | Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. ( Aström, E; Söderhäll, S, 2002) |
| "Treatment with pamidronate normalized serum calcium concentration and induced a complete biochemical remission." | 1.28 | Paget's disease with osteolytic lesions: combining medical and surgical treatments. ( Bloem, RM; Brumsen, C; Papapoulos, SE, 1992) |
| "There were seven patients with breast cancer, eight with lung cancer, and ten with a variety of other cancers." | 1.28 | Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemia. ( Cantwell, BM; Carmichael, J; Harris, AL; Mannix, KA, 1989) |
| "Eight patients suffered a recurrence after discontinuation of APD." | 1.27 | Quantitative bone scintigraphy in Paget's disease treated with APD. ( Bijvoet, OL; Frijlink, WB; Harinck, HI; Pauwels, EK; Vellenga, CJ, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (9.76) | 18.7374 |
| 1990's | 8 (19.51) | 18.2507 |
| 2000's | 19 (46.34) | 29.6817 |
| 2010's | 7 (17.07) | 24.3611 |
| 2020's | 3 (7.32) | 2.80 |
| Authors | Studies |
|---|---|
| Stojkic, I | 1 |
| Rubin, E | 1 |
| Lee, J | 2 |
| Lee, ASE | 1 |
| Ogbu, EA | 1 |
| Satyarengga, M | 1 |
| Silver, KD | 1 |
| Kaneko, S | 1 |
| Shimizu, M | 1 |
| Inoue, N | 1 |
| Mizuta, M | 1 |
| Yachie, A | 1 |
| Krishnan, S | 1 |
| Rughani, A | 1 |
| Tsai, A | 1 |
| Palle, S | 1 |
| Andreasen, CM | 1 |
| Jurik, AG | 1 |
| Glerup, MB | 1 |
| Høst, C | 1 |
| Mahler, BT | 1 |
| Hauge, EM | 1 |
| Herlin, T | 1 |
| Hospach, T | 1 |
| Langendoerfer, M | 1 |
| von Kalle, T | 1 |
| Maier, J | 1 |
| Dannecker, GE | 1 |
| Kuijpers, SC | 1 |
| de Jong, E | 1 |
| Hamdy, NA | 1 |
| van Merkesteyn, JP | 1 |
| Morimoto, A | 1 |
| Shioda, Y | 1 |
| Imamura, T | 1 |
| Kanegane, H | 1 |
| Sato, T | 1 |
| Kudo, K | 1 |
| Nakagawa, S | 1 |
| Nakadate, H | 1 |
| Tauchi, H | 1 |
| Hama, A | 1 |
| Yasui, M | 1 |
| Nagatoshi, Y | 1 |
| Kinoshita, A | 1 |
| Miyaji, R | 1 |
| Anan, T | 1 |
| Yabe, M | 1 |
| Kamizono, J | 1 |
| Conejo-Fernández, A | 1 |
| Núñez Cuadros, E | 1 |
| Jiménez Hinojosa, JM | 1 |
| Urda Cardona, AL | 1 |
| Kim, YS | 1 |
| Kim, HS | 1 |
| Papapetrou, PD | 1 |
| Bergi-Stamatelou, M | 1 |
| Karga, H | 1 |
| Thanou, S | 1 |
| Chen, BE | 1 |
| Cook, RJ | 1 |
| Amital, H | 1 |
| Applbaum, YH | 1 |
| Aamar, S | 1 |
| Daniel, N | 1 |
| Rubinow, A | 1 |
| Wenzel, C | 1 |
| Bartsch, R | 1 |
| Hussian, D | 1 |
| Pluschnig, U | 1 |
| Locker, GJ | 1 |
| Sevelda, U | 1 |
| Zielinski, CC | 1 |
| Steger, GG | 1 |
| Merigo, E | 1 |
| Manfredi, M | 1 |
| Meleti, M | 1 |
| Corradi, D | 1 |
| Vescovi, P | 1 |
| Cheng, CJ | 1 |
| Chou, CH | 1 |
| Lin, SH | 1 |
| Attal, M | 1 |
| Harousseau, JL | 1 |
| Leyvraz, S | 1 |
| Doyen, C | 1 |
| Hulin, C | 1 |
| Benboubker, L | 1 |
| Yakoub Agha, I | 1 |
| Bourhis, JH | 1 |
| Garderet, L | 1 |
| Pegourie, B | 1 |
| Dumontet, C | 1 |
| Renaud, M | 1 |
| Voillat, L | 1 |
| Berthou, C | 1 |
| Marit, G | 1 |
| Monconduit, M | 1 |
| Caillot, D | 1 |
| Grobois, B | 1 |
| Avet-Loiseau, H | 1 |
| Moreau, P | 1 |
| Facon, T | 1 |
| Lucarelli, S | 1 |
| Borrelli, O | 1 |
| Paganelli, M | 1 |
| Capocaccia, P | 1 |
| Frediani, T | 1 |
| Ferri, F | 1 |
| Cucchiara, S | 1 |
| Yamazaki, Y | 1 |
| Satoh, C | 1 |
| Ishikawa, M | 1 |
| Notani, K | 1 |
| Nomura, K | 1 |
| Kitagawa, Y | 1 |
| Compeyrot-Lacassagne, S | 1 |
| Rosenberg, AM | 1 |
| Babyn, P | 1 |
| Laxer, RM | 1 |
| Sanna, G | 1 |
| Preda, L | 1 |
| Bruschini, R | 1 |
| Cossu Rocca, M | 1 |
| Verri, E | 1 |
| Bellomi, M | 1 |
| Goldhirsch, A | 1 |
| Nole, F | 1 |
| Ramasamy, B | 1 |
| Quah, S | 1 |
| Sahni, JN | 1 |
| Palimar, P | 1 |
| Simm, PJ | 1 |
| Allen, RC | 1 |
| Zacharin, MR | 1 |
| Gleeson, H | 1 |
| Wiltshire, E | 1 |
| Briody, J | 1 |
| Hall, J | 1 |
| Chaitow, J | 1 |
| Sillence, D | 1 |
| Cowell, C | 1 |
| Munns, C | 1 |
| Macarol, V | 1 |
| Fraunfelder, FT | 1 |
| Grutters, JC | 1 |
| Hermus, AR | 1 |
| de Mulder, PH | 1 |
| Beex, LV | 1 |
| Gutteridge, DH | 1 |
| Retallack, RW | 1 |
| Ward, LC | 1 |
| Stuckey, BG | 1 |
| Stewart, GO | 1 |
| Prince, RL | 1 |
| Kent, GN | 1 |
| Bhagat, CI | 1 |
| Price, RI | 1 |
| Thompson, RI | 1 |
| Nicholson, GC | 1 |
| Williams, CJ | 1 |
| Smith, RA | 1 |
| Ball, RJ | 1 |
| Wilkinson, H | 1 |
| Goodnight, SH | 1 |
| Feinstein, DI | 1 |
| Body, JJ | 1 |
| Louviaux, I | 1 |
| Dumon, JC | 1 |
| Coinde, E | 1 |
| David, L | 1 |
| Cottalorda, J | 1 |
| Allard, D | 1 |
| Bost, M | 1 |
| Lucht, F | 1 |
| Stéphan, JL | 1 |
| Lortholary, A | 1 |
| Aström, E | 1 |
| Söderhäll, S | 1 |
| Savage, DG | 1 |
| Mears, JG | 1 |
| Balmaceda, C | 1 |
| Rescigno, J | 1 |
| Shendrik, I | 1 |
| Mansukhani, M | 1 |
| Orazi, A | 1 |
| Brumsen, C | 1 |
| Bloem, RM | 1 |
| Papapoulos, SE | 1 |
| Vega, EM | 1 |
| Mautalen, CA | 2 |
| Judson, I | 1 |
| Booth, F | 1 |
| Gore, M | 1 |
| McElwain, T | 1 |
| Ralston, SH | 1 |
| Gallacher, SJ | 1 |
| Patel, U | 1 |
| Dryburgh, FJ | 1 |
| Fraser, WD | 1 |
| Cowan, RA | 1 |
| Boyle, IT | 1 |
| Mannix, KA | 1 |
| Carmichael, J | 1 |
| Harris, AL | 1 |
| Cantwell, BM | 1 |
| Vellenga, CJ | 1 |
| Pauwels, EK | 1 |
| Bijvoet, OL | 1 |
| Harinck, HI | 1 |
| Frijlink, WB | 1 |
| Gonzalez, D | 1 |
| Ghiringhelli, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for pamidronate and Recrudescence
| Article | Year |
|---|---|
Chronic recurrent multifocal osteomyelitis with myositis: A case report and review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Chronic Disease; C | 2020 |
Update in hematology.
Topics: Anemia; Anticoagulants; Antineoplastic Agents; Chemotherapy, Adjuvant; Diphosphonates; Female; Hepar | 1998 |
[Tumor-induced hypercalcemia. Review of bisphosphonate treatment].
Topics: Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Etidronic Acid; Fluid Therapy; Hematolog | 2001 |
Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Combined Modality Thera | 2002 |
5 trials available for pamidronate and Recrudescence
| Article | Year |
|---|---|
SAPHO syndrome treated with pamidronate: an open-label study of 10 patients.
Topics: Acquired Hyperostosis Syndrome; Adult; Aged; Anti-Inflammatory Agents; Diphosphonates; Drug Administ | 2004 |
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Diphosphonates; Disease-Free Su | 2006 |
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Bone and Bones; Diphosphonates; | 1996 |
Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia.
Topics: Adult; Aged; Anti-Inflammatory Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcem | 2000 |
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.
Topics: Administration, Oral; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Drug Administration | 1989 |
32 other studies available for pamidronate and Recrudescence
| Article | Year |
|---|---|
An unusual presentation of chronic recurrent multifocal osteomyelitis involving bones of the skull.
Topics: Adolescent; Child; Chronic Disease; Diagnostic Imaging; Humans; Male; Osteomyelitis; Pamidronate; Re | 2023 |
Severe hypercalcaemia due to household cleaner ingestion.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Bone Density Conservation Agents; Eating; Household P | 2019 |
Novel compound heterozygous variants in the
Topics: Bone Density Conservation Agents; Dwarfism; Exome Sequencing; Female; Heterozygote; Humans; Infant; | 2021 |
Response to Early-onset Pamidronate Treatment in Chronic Nonbacterial Osteomyelitis: A Retrospective Single-center Study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Denmar | 2019 |
Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.
Topics: Adolescent; Back Pain; Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Fem | 2010 |
Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.
Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Female; Follow-Up | 2011 |
Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan.
Topics: Adolescent; Child; Child, Preschool; Diphosphonates; Disease-Free Survival; Drug Evaluation; Drug-Re | 2011 |
[Pamidronate: a therapeutic alternative in chronic recurrent mutifocal osteomyelitis].
Topics: Child; Chronic Disease; Diphosphonates; Female; Humans; Osteomyelitis; Pamidronate; Recurrence | 2011 |
Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis.
Topics: Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphosphonates; Drug Therapy, Combinat | 2013 |
Hypercalcemia due to sun exposure in a patient with multiple myeloma and elevated parathyroid hormone-related protein.
Topics: Adult; Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal; Diphosphonates; Humans; Hyperc | 2003 |
Tests for multivariate recurrent events in the presence of a terminal event.
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Computer Simulation; Data Interpretation, S | 2004 |
Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome.
Topics: Bone Resorption; Breast Neoplasms; Diphosphonates; Drug Resistance; Female; Humans; Hypercalcemia; I | 2004 |
Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Topics: Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Neoplasms; Curettage; Diphosphon | 2005 |
An unrecognized cause of recurrent hypercalcemia: immobilization.
Topics: Aged; Bone Density Conservation Agents; Calcium; Diphosphonates; Exercise Therapy; Gout; Humans; Hyp | 2006 |
Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate.
Topics: Back Pain; Bone Density; Bone Density Conservation Agents; Child; Colitis, Ulcerative; Diphosphonate | 2006 |
Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate.
Topics: Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Humans; Male; Mandibular D | 2007 |
Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Chronic Disease; Diphosphonates; Female; Humans; | 2007 |
The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates.
Topics: Adenocarcinoma; Bone Neoplasms; Bone Plates; Bone Screws; Breast Neoplasms; Cutaneous Fistula; Dipho | 2008 |
Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
Topics: Acute Disease; Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density Co | 2007 |
Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Child; Chronic Disease; Diphosphonates; Female; Humans; Male; Osteomyelitis; Pamidronate | 2008 |
Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape.
Topics: Adolescent; Anti-Inflammatory Agents; Bone Density; Child; Child, Preschool; Diphosphonates; Female; | 2008 |
Pamidronate disodium and possible ocular adverse drug reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Conjunctivitis; Diphosphonates; Drug Hypersensitivity; H | 1994 |
Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphate (APD).
Topics: Adult; Aged; Breast Neoplasms; Calcium; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalc | 1993 |
Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
Topics: Adolescent; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Male; Osteogenesis Imperf | 1997 |
[Chronic recurrent multifocal osteomyelitis in children: report of 17 cases].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Bone and Bones; Child; Child, Pr | 2001 |
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.
Topics: Absorptiometry, Photon; Adolescent; Biomarkers; Bone Density; Bone Remodeling; Child; Child, Prescho | 2002 |
Paget's disease with osteolytic lesions: combining medical and surgical treatments.
Topics: Combined Modality Therapy; Diphosphonates; Femur; Humans; Hyperparathyroidism; Male; Middle Aged; Os | 1992 |
Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma.
Topics: Adult; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Pam | 1991 |
Chronic high-dose pamidronate in refractory malignant hypercalcaemia.
Topics: Diphosphonates; Drug Tolerance; Humans; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Pamidron | 1990 |
Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemia.
Topics: Adult; Aged; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalcemia; Hypocalcemia; Infusio | 1989 |
Quantitative bone scintigraphy in Paget's disease treated with APD.
Topics: Diphosphonates; Follow-Up Studies; Humans; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Re | 1985 |
Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
Topics: Adult; Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged | 1985 |